Boylan James P has filed 9 insider transactions across 4 companies since October 2023.
Most recent transaction: a grant/award of 90000 shares of Compass Therapeutics, Inc. ($CMPX) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Compass Therapeutics, Inc. | $CMPX | Boylan James P | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| June 25, 2025 | Camp4 Therapeutics Corp | $CAMP | Boylan James P | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| June 10, 2025 | Zenas BioPharma, Inc. | $ZBIO | Boylan James P | Director | A | Stock Option (Right to Buy) | 18500 | $0.00 | 18,500.0000 | 41,800,802 | 9999.99% | 0.04% |
| June 10, 2025 | Immunome Inc. | $IMNM | Boylan James P | Not found | A | Director Stock Option (right to buy) | 18864 | $0.00 | 18,864.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Compass Therapeutics, Inc. | $CMPX | Boylan James P | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 12, 2024 | Zenas BioPharma, Inc. | $ZBIO | Boylan James P | Director | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 1,567,269 | 9999.99% | 2.36% |
| June 13, 2024 | Immunome Inc. | $IMNM | Boylan James P | Not found | A | Stock option (right to buy) | 11333 | $0.00 | 11,333.0000 | 0 | 9999.99% | 0.00% |
| March 8, 2024 | Compass Therapeutics, Inc. | $CMPX | Boylan James P | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2023 | Immunome Inc. | $IMNM | Boylan James P | Director | A | Stock option (right to buy) | 41538 | $0.00 | 41,538.0000 | 0 | 9999.99% | 0.00% |